Display options
Cite
Petrescu MO, Rădulescu D, Marinescu D, et al. Preoperative Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Lymphocyte-Monocyte Ratio in Peripheral Blood of Patients with Gastrointestinal Malignant Lesions. Curr Health Sci J. 2019;45(3):285-290doi: 10.12865/CHSJ.45.03.06.
Petrescu, M. O., Rădulescu, D., Marinescu, D., Șurlin, V., Bordu, S., & Petrescu, G. S. (2019). Preoperative Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Lymphocyte-Monocyte Ratio in Peripheral Blood of Patients with Gastrointestinal Malignant Lesions. Current health sciences journal, 45(3), 285-290. https://doi.org/10.12865/CHSJ.45.03.06
Petrescu, M O, et al. "Preoperative Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Lymphocyte-Monocyte Ratio in Peripheral Blood of Patients with Gastrointestinal Malignant Lesions." Current health sciences journal vol. 45,3 (2019): 285-290. doi: https://doi.org/10.12865/CHSJ.45.03.06
Petrescu MO, Rădulescu D, Marinescu D, Șurlin V, Bordu S, Petrescu GS. Preoperative Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Lymphocyte-Monocyte Ratio in Peripheral Blood of Patients with Gastrointestinal Malignant Lesions. Curr Health Sci J. 2019 Jul-Sep;45(3):285-290. doi: 10.12865/CHSJ.45.03.06. Epub 2019 Sep 30. PMID: 32042456; PMCID: PMC6993767.
Copy Download .nbib Format: NLM
Share it on

Curr Health Sci J. 2019 Jul-Sep;45(3):285-290. doi: 10.12865/CHSJ.45.03.06. Epub 2019 Sep 30.

Preoperative Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Lymphocyte-Monocyte Ratio in Peripheral Blood of Patients with Gastrointestinal Malignant Lesions.

Current health sciences journal

M O Petrescu, D Rădulescu, D Marinescu, V Șurlin, S Bordu, G S Petrescu

Affiliations

  1. PhD student, University of Medicine and Pharmacy of Craiova, Romania.
  2. Department I of Surgery, University of Medicine and Pharmacy of Craiova, Romania.

PMID: 32042456 PMCID: PMC6993767 DOI: 10.12865/CHSJ.45.03.06

Abstract

Local inflammation plays a very important role in the apparition and development of tumors and metastasis. The objective of this study was to investigate the significance of neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR) and platelet to lymphocyte ratio (PLR) in peripheral blood of patients with gastrointestinal malignant tumors.

METHODS: Medical records of 145 patients diagnosed with gastrointestinal malignant tumor between January 2017 and December 2017 were analyzed retrospectively. Pretreatment neutrophil, lymphocyte, platelet and monocyte counts and NLR, LMR and PLR were investigated.

RESULTS: The mean for NLR, PLR and LMR in patients with gastrointestinal cancer were determined.

CONCLUSIONS: Determination of NLR, PLR and LMR can be easily done with a simple blood test and may be useful inflammatory markers as in our study we have observed the presence of increased inflammatory response in patients with gastrointestinal cancer.

Copyright © 2019, Medical University Publishing House Craiova.

Keywords: Lymphocyte to monocyte ratio (LMR); cancer; gastrointestinal; malign lesions; neutrophil to lymphocyte ratio (NLR); platelet to lymphocyte ratio (PLR)

References

  1. BMC Res Notes. 2017 Jan 3;10(1):12 - PubMed
  2. Scand J Gastroenterol. 2017 Feb;52(2):209-215 - PubMed
  3. PLoS One. 2014 Nov 06;9(11):e112361 - PubMed
  4. J Clin Invest. 2015 Sep;125(9):3347-55 - PubMed
  5. Oncotarget. 2017 May 23;8(21):35165-35175 - PubMed
  6. Int J Cancer. 2010 Dec 15;127(12):2893-917 - PubMed
  7. Onco Targets Ther. 2015 Sep 11;8:2527-33 - PubMed
  8. Crit Rev Oncol Hematol. 2017 Aug;116:134-146 - PubMed
  9. Int J Cancer. 2019 Apr 15;144(8):1941-1953 - PubMed
  10. Viruses. 2017 Sep 12;9(9): - PubMed
  11. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 - PubMed
  12. Nature. 2002 Dec 19-26;420(6917):860-7 - PubMed
  13. Nat Rev Cancer. 2004 Jan;4(1):71-8 - PubMed
  14. Virology. 2009 Sep 15;392(1):1-10 - PubMed
  15. Int J Infect Dis. 2017 Dec;65:15-21 - PubMed
  16. Pancreas. 2019 Sep;48(8):1098-1101 - PubMed
  17. Niger J Clin Pract. 2018 Jan;21(1):49-53 - PubMed
  18. Int J Cancer. 2015 Mar 1;136(5):E359-86 - PubMed
  19. Cancer Lett. 2014 Apr 10;345(2):235-41 - PubMed
  20. Sci Rep. 2017 Dec 1;7(1):16717 - PubMed
  21. Medicine (Baltimore). 2018 Jun;97(26):e11138 - PubMed
  22. Oncotarget. 2016 May 31;7(22):33210-9 - PubMed
  23. Nature. 2008 Jul 24;454(7203):436-44 - PubMed
  24. CA Cancer J Clin. 2015 Mar;65(2):87-108 - PubMed
  25. Oncotarget. 2016 May 31;7(22):31926-42 - PubMed
  26. Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10025-30 - PubMed
  27. Tumour Biol. 2017 Oct;39(10):1010428317714195 - PubMed
  28. Cell. 2010 Mar 19;140(6):883-99 - PubMed

Publication Types